Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Christian Prünte"'
Publikováno v:
International Journal of Retina and Vitreous, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Purpose To evaluate the clinical outcome of subretinal autologous internal limiting membrane (ILM) transplantation during pars-plana vitrectomy for persistent full-thickness macular hole (FTMH) repair. Methods Retrospective, consecutive case
Externí odkaz:
https://doaj.org/article/443289cde5404b18848e071206e5babe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laura Hoffmann, Cengiz Türksever, Alexandra Behrndt, Maria-Magdalena Guichard, Helena Giannakaki-Zimmermann, Christian Prünte, Katja Hatz
Publikováno v:
Ophthalmic Res
Purpose: The purpose of the study was to investigate longer term functional and morphological outcomes and their predictors in diabetic macular edema (DME) following a treat-and-extend regimen (TER) without loading dose under ranibizumab. Methods: Pa
Autor:
Katja Hatz, Christian Prünte
Publikováno v:
Retina. 37:1185-1192
PURPOSE To evaluate aflibercept treat-and-extend regimen for treatment of neovascular age-related macular degeneration in patients with limited response to ranibizumab. METHODS This prospective single-arm trial included 33 patients with neovascular a
Publikováno v:
Diabetes Research and Clinical Practice. 126:1-9
Diabetes is a growing worldwide epidemic and a leading cause of blindness in working-age people around the world. Diabetic retinopathy (DR) and diabetic macular edema (DME) are common causes of visual impairment in people with diabetes and often indi
Iron can exert oxidative damage, and increased accumulation is believed to play a role in age-related macular degeneration. Hereditary hemochromatosis leads to an increase in total body iron. Patients with HH were assessed for drusen and other retina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0782629b82c504906960c7c74d15b224
https://ora.ox.ac.uk/objects/uuid:03df4989-ca0c-4b35-8c39-6660ee77a2d9
https://ora.ox.ac.uk/objects/uuid:03df4989-ca0c-4b35-8c39-6660ee77a2d9
Autor:
Christian Prünte, Katja Hatz
Publikováno v:
Acta Ophthalmologica. 95:e67-e72
PURPOSE To compare outcomes in patients with treatment-naive neovascular age-related macular degeneration (nAMD) receiving ranibizumab treat and extend (TE) with those receiving ranibizumab pro re nata (PRN) in a clinical setting. METHODS During this
Autor:
Christian Prünte, Katja Hatz
Publikováno v:
British Journal of Ophthalmology. 100:1341-1345
Background Treat and extend (TE) treatment regimens have the potential to reduce the treatment burden placed upon patients receiving ranibizumab for neovascular age-related macular degeneration (nAMD). This study aimed to analyse changes in best corr
Autor:
P Bernhard Henrich, Christian Prünte, Katja Hatz, Ulrike Schneider, Beatrice Braun, Stefan Sacu
Publikováno v:
Ophthalmologica. 233:66-73
Purpose: To investigate the injection frequency and visual acuity (VA) outcomes with combination therapy (ranibizumab plus verteporfin photodynamic therapy, PDT) versus monotherapy (ranibizumab). Methods: A total of 40 patients with exudative age-rel
Publikováno v:
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. 238(3)
Purpose: To evaluate outcome predictors of aflibercept in neovascular age-related macular degeneration pretreated with ranibizumab based on a treat-and-extend regimen (TER). Methods: We performed a retrospective evaluation of 18-month follow-up of 45